← AlphaSignal

ABBV

★★☆☆☆ Passmistral

AbbVie Inc.

Healthcare · sector percentile 43

Session move

$261.83

−$4.14-1.56%

Vol 0.96× avg

51/100 quant · tgt $276.41

ADV$ 1355.1M

session 2026-08-20 · Snapshot — not live tape

Since last scan

2026-08-19 → 2026-08-20

Score-0.9Price+$7.05 · +2.72%Disclosure+8.0Filingsattention

Context only — not a buy/sell signal. Built from scan history and cached news/filings.

Snapshot quote

session 2026-08-20 · scan 2026-08-20 · pushed 2026-08-20T23:58 · After hours (stale)

Show quote fundamentals
Last (scan/close)
$265.97
Previous close
$265.97
Pushed last
$261.83 (stale) · After hours
Session open
$265.69
Last session range
$260.48 – $265.93
52-week range
$241.20 – $267.47
Session volume
5,125,696
Avg volume (20d)
5,359,316
Market cap
$470.00B
PE (TTM)
73.07
Forward PE
16.37
Dividend yield
2.64%
1y target est.
$276.41
Next earnings
2026-10-29

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. Pre/after-hours quotes are thinner and may differ from the regular session.

Market briefing

Curated digest — not a trade signal. Headlines and links as provided by the producer.

No recent headlines for this ticker.

Reddit mentions

Public Reddit titles via the official API — unofficial, delayed, not a trade signal. Not affiliated with Reddit. Opens Reddit.

No recent Reddit titles matched this ticker.

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

  • Bull Thesis — AbbVie's strong EPS growth (2.9x YoY) and momentum (27.9% 3M) offset valuation concerns, with Humira biosimilar erosion stabilizing and pipeline assets (e.g., Skyrizi, Rinvoq) driving long-term revenue resilience.
  • Risks — High trailing P/E (73x) and debt-to-equity concerns (3.2x) remain key risks amid patent cliffs and biosimilar competition pressure on legacy products.
  • Target Upside — Mean price target of $276.41 implies 4.0% upside from current $265.97, aligning with analyst consensus and modest valuation expansion.

Score History

2026-07-3050.8 pts · 2026-08-20

16 days of scans. Daily batch adds the next weekday automatically while the API is running.

  • DatePriceChgScoreRating
  • 2026-08-20$265.97+$7.0550.8Pass
  • 2026-08-19$258.92+$8.5951.7Pass
  • 2026-08-18$250.33+$0.8752.9Pass
  • 2026-08-17$249.46−$1.3653.0Pass
  • 2026-08-14$250.82+$0.7152.7Pass
  • 2026-08-13$250.11+$0.0252.8Pass
  • 2026-08-12$250.09+$2.1252.8Pass
  • 2026-08-11$247.97+$1.9353.2Pass
  • 2026-08-10$246.04+$2.1753.3Pass
  • 2026-08-07$243.87−$2.3353.4Pass
  • 2026-08-06$246.20+$2.4053.0Pass
  • 2026-08-05$243.80−$1.3052.5Pass
  • 2026-08-03$245.10−$5.8452.8Pass
  • 2026-08-01$250.94−$1.9351.9Pass
  • 2026-07-31$252.87−$4.5432.2Pass
  • 2026-07-30$257.41—31.6Pass

Quant Breakdown

Revenue Growth
4.1
EPS Growth
16.0
ROE
0.0
PER Relative
0.0
Debt / Equity
3.2
FCF Margin
8.0
Analyst Upside
1.3
Insider / Sector
2.0
Momentum 3M
12.0
Earn. Surprise
4.2

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

Elevated vs 20das of 2026-08-20 · finra_cnms
Short / total
71.0%
vs 20d (z)
2.72
Short vol
1,375,530
Status
ok

Squeeze pressure score

full

64/100

Short leg
69
Call leg
74
Activity
2.0
Call vol share
69.1%
PCR (vol)
0.45
Call OI share
75.8%
ATM IV
41.1%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

Disclosure score

Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.

Disclosure score

-6

as of 2026-08-20 · mongo_cache_only
News
+2
Insider
-8
Earnings
0

Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.

Risk (−)

Insider open-market sell↗

Attention (~)

8-K Item 8.01 — other events (attention only)↗

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

Earnings surprise (quant context)

From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.

Last reported surprise +2.9%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-08-18·sec_edgar·CIK 0001551152
Next earnings
2026-10-29yahoo_calendar
Last earnings
—

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.